Evidence map›Paper›PMID 42284702›Full record

ArticleBlood advances2026

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Jean-Roch Le Henaff, Loïc Le Guennec, Pauline Schiro, Kevin Bihan, Jacques Gasnault, Bruno Stankoff, Yassine Taoufik, Emmanuel Treiner, Danièle Bensoussan, Sébastien Lhomme and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Jean-Roch Le HenaffDepartment of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France.ORCID 0009-0001-8717-0365
Loïc Le GuennecService de Médecine Intensive Réanimation à orientation neurologique, Sorbonne Université, Hôpital de la Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0001-8146-6256
Pauline SchiroDepartment of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology, Clinical Investigation Center 1436, Faculty of Medicine, Toulouse University Hospital, Toulouse, France.ORCID 0009-0003-5274-1062
Kevin BihanOncoNeuroTox ICU Study Group, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.ORCID 0000-0001-6797-0237
Jacques GasnaultUnit of Neuroinfectious Rehabilitation, Department of Internal Medicine and Clinical Immunology, Bicêtre University Hospital, Le Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France.
Bruno StankoffNeurology Department, Sorbonne University, Paris Brain Institute, INSERM, CNRS, Pitié Salpetriere Hospital, APHP, Paris, France.
Yassine TaoufikINSERM U1356, Gustave Roussy Institute, Villejuif, France.
Emmanuel TreinerNeo-I3D Research Group, Toulouse University Hospital, Toulouse, France.
Danièle BensoussanCell Therapy Unit, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
Sébastien LhommeNeo-I3D Research Group, Toulouse University Hospital, Toulouse, France.ORCID 0000-0001-7908-1576
Anne-Sophie L'HonneurDepartment of Virology, Paris Cité University, Cochin Hospital, Paris, France.ORCID 0000-0002-9228-0649
Fabrice BonnevilleDepartment of Neuroradiology, Toulouse University Hospital, Toulouse, France.ORCID 0000-0002-1977-5987
Natalia ShorDepartment of Neuroradiology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.ORCID 0000-0003-0693-1829
Valérie PourcherDepartment of Infectious Diseases, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Béatrice PignoletNeo-I3D Research Group, Toulouse University Hospital, Toulouse, France.
Baptiste LievinDepartment of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France.
Clément JavauxDepartment of Infectious and Tropical Diseases, Croix Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.
Julien Le GuenService de Gériatrie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0002-4104-1170
Eolia BrissotService d'Hématologie Clinique et Thérapie Cellulaire, Centre de Recherche de Saint-Antoine, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, INSERM, UMRs938, Paris, France.ORCID 0000-0003-4471-418X
Pierre-Antoine LimouzinDepartment of Neurology, CHU Pellegrin, Bordeaux, France.
Clémence RichaudDepartment of Infectious and Tropical Diseases, CHU Gabriel Montpied, Clermont-Ferrand, France.ORCID 0000-0001-8100-6057
Bruno LioureUnité de Greffe de Cellules Souches Hématopoïétiques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Thomas WirthDepartment of Neurology, University Hospital of Strasbourg, Strasbourg, France.ORCID 0000-0002-4427-5765
Paul PetitgasDepartment of Infectious and Tropical Diseases, Quimper Hospital, Quimper, France.
Simon HerbelService de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0002-1346-4926
François CoustillèresDepartment of Infectious Diseases, Tours University Hospital, Tours, France.ORCID 0000-0002-4034-9341
Elena-Camelia RusuDepartment of Neurology, Toulon Hospital, Toulon, France.
Laura MaertenDepartment of Internal Medicine, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.
Aurore PerrotDepartment of Hematology, Toulouse University Hospital, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse University, Toulouse, France.ORCID 0000-0003-0131-8689
Agnès SommetNeo-I3D Research Group, Toulouse University Hospital, Toulouse, France.
Damien Roos-WeilHematology Unit, CHU Pitié-Salpêtrière, Sorbonne Université, Paris, France.ORCID 0000-0002-7767-755X
Margaux LafaurieNeo-I3D Research Group, Toulouse University Hospital, Toulouse, France.ORCID 0000-0001-6010-2891
Nicolas WeissOncoNeuroTox ICU Study Group, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.ORCID 0000-0001-5155-196X
Guillaume Martin-BlondelDepartment of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France.ORCID 0000-0002-8363-7028
THEOREM Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42284702
PMCPMC13508629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.